Clinical Trial Update: Prostate MRI and Pylarify PSMA PET/CT [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating prostate MRI and Pylarify PSMA PET/CT for prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pylarify (piflufolastat F-18)

Snippet

Sponsor: Corewell Health East | Conditions: Prostate Cancer | Phase 4 | Status: WITHDRAWN